drugset

drugset / Trial / NCT01222299

Safety, Pharmacokinetics, and Efficacy of Bepotastine Besilate Nasal Product After Ragweed Pollen Exposure in an Environmental Chamber

NCT01222299 ↗

Phase 1/2 Completed 89 enrolled Bausch & Lomb Incorporated

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to examine the safety and efficacy of bepotastine besilate nasal product in seasonal allergic rhinitis patients.

Timeline

Start: 2010-05
Primary completion: 2010-08
Completion: 2010-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bepotastine	Small molecule	—	Other

Indications